Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension

Author： Chhina Mantej K   Nargues Weir   Grant Geraldine M   Nathan Steven D  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.6, Iss.1, 2010-01, pp. : 19-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 2, 2012-01 ,pp. : 100-104

Bentham Science Publishers

Access to resources Recommend Favorite

Current Treatment of the Pulmonary Arterial Hypertension

By  

Current Respiratory Medicine Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension: A Comprehensive Review of Pharmacological Treatment

By Erika Berman Rosenzweig   Barst Robyn J.  

Treatments in Respiratory Medicine, Vol. 5, Iss. 2, 2006-01 ,pp. : 117-127

Adis International

Access to resources Recommend Favorite

Vasoproliferation and Antiproliferative Treatment Options in Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 142-149

Bentham Science Publishers

Access to resources Recommend Favorite

N-Terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension

By Dimitroulas Theodoros   Giannakoulas Georgios   Karvounis Haralambos   Koliakos Georgios   Sfetsios Tilemahos   Dimitroula Hara   Settas Loukas  

Clinical Rheumatology, Vol. 27, Iss. 5, 2008-05 ,pp. : 655-658

Springer Publishing Company

Access to resources Recommend Favorite